Evaluation of Nitric Oxide-Donating Properties of 11H-indeno[1,2-b]quinoxalin-11-one Oxime (IQ-1) by Electron Paramagnetic Resonance Spectroscopy; Molecules; Vol. 29, iss. 16

Bibliographische Detailangaben
Parent link:Molecules.— .— Basel: MDPI AG
Vol. 29, iss. 16.— 2024.— Article number 3820, 11 p.
Körperschaft: National Research Tomsk Polytechnic University (570)
Weitere Verfasser: Andrianov V. V., Schepetkin (Shchepyotkin) I. A. Igor Aleksandrovich, Bazan L. V., Gainutdinov K. L., Kovrizhina A. R. Anastasia Ruslanovna, Atochin D. N. Dmitry Nikolaevich, Khlebnikov A. I. Andrey Ivanovich
Zusammenfassung:Title screen
IQ-1 (11H-indeno[1,2-b]quinoxalin-11-one oxime) is a specific c-Jun N-terminal kinase (JNK) inhibitor with anticancer and neuro- and cardioprotective properties. Because aryloxime derivatives undergo cytochrome P450-catalyzed oxidation to nitric oxide (NO) and ketones in liver microsomes, NO formation may be an additional mechanism of IQ-1 pharmacological action. In the present study, electron paramagnetic resonance (EPR) of the Fe2+ complex with diethyldithiocarbamate (DETC) as a spin trap and hemoglobin (Hb) was used to detect NO formation from IQ-1 in the liver and blood of rats, respectively, after IQ-1 intraperitoneal administration (50 mg/kg). Introducing the spin trap and IQ-1 led to signal characteristics of the complex (DETC)2-Fe2+-NO in rat liver. Similarly, the introduction of the spin trap components and IQ-1 resulted in an increase in the Hb-NO signal for both the R- and the T-conformers in blood samples. The density functional theory (DFT) calculations were in accordance with the experimental data and indicated that the NO formation of IQ-1 through the action of superoxide anion radical is thermodynamically favorable. We conclude that the administration of IQ-1 releases NO during its oxidoreductive bioconversion in vivo
Текстовый файл
Sprache:Englisch
Veröffentlicht: 2024
Schlagworte:
Online-Zugang:https://doi.org/10.3390/molecules29163820
Format: Elektronisch Buchkapitel
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=675620

MARC

LEADER 00000naa0a2200000 4500
001 675620
005 20241017105431.0
090 |a 675620 
100 |a 20241017d2024 k||y0rusy50 ba 
101 0 |a eng 
102 |a CH 
135 |a drcn ---uucaa 
181 0 |a i   |b  e  
182 0 |a b 
183 0 |a cr  |2 RDAcarrier 
200 1 |a Evaluation of Nitric Oxide-Donating Properties of 11H-indeno[1,2-b]quinoxalin-11-one Oxime (IQ-1) by Electron Paramagnetic Resonance Spectroscopy  |f Viacheslav V. Andrianov, Igor A. Schepetkin, Leah V. Bazan [et al.] 
203 |a Текст  |b визуальный  |c электронный 
283 |a online_resource  |2 RDAcarrier 
300 |a Title screen 
320 |a References: 54 tit. 
330 |a IQ-1 (11H-indeno[1,2-b]quinoxalin-11-one oxime) is a specific c-Jun N-terminal kinase (JNK) inhibitor with anticancer and neuro- and cardioprotective properties. Because aryloxime derivatives undergo cytochrome P450-catalyzed oxidation to nitric oxide (NO) and ketones in liver microsomes, NO formation may be an additional mechanism of IQ-1 pharmacological action. In the present study, electron paramagnetic resonance (EPR) of the Fe2+ complex with diethyldithiocarbamate (DETC) as a spin trap and hemoglobin (Hb) was used to detect NO formation from IQ-1 in the liver and blood of rats, respectively, after IQ-1 intraperitoneal administration (50 mg/kg). Introducing the spin trap and IQ-1 led to signal characteristics of the complex (DETC)2-Fe2+-NO in rat liver. Similarly, the introduction of the spin trap components and IQ-1 resulted in an increase in the Hb-NO signal for both the R- and the T-conformers in blood samples. The density functional theory (DFT) calculations were in accordance with the experimental data and indicated that the NO formation of IQ-1 through the action of superoxide anion radical is thermodynamically favorable. We conclude that the administration of IQ-1 releases NO during its oxidoreductive bioconversion in vivo 
336 |a Текстовый файл 
461 1 |t Molecules  |c Basel  |n MDPI AG 
463 1 |t Vol. 29, iss. 16  |v Article number 3820, 11 p.  |d 2024 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a c-Jun N-terminal kinase (JNK) inhibitor 
610 1 |a IQ-1 (11H-indeno[1,2-b]quinoxalin-11-one oxime) 
610 1 |a electron paramagnetic resonance 
610 1 |a nitric oxide donor 
610 1 |a spin trap 
610 1 |a hemoglobin 
610 1 |a DFT calculation 
701 1 |a Andrianov  |b V. V. 
701 1 |a Schepetkin (Shchepyotkin)  |b I. A.  |c doctor-biophysicist  |c leading researcher of Tomsk Polytechnic University, candidate of medical science  |f 1962-  |g Igor Aleksandrovich  |9 20276 
701 1 |a Bazan  |b L. V. 
701 1 |a Gainutdinov  |b K. L. 
701 1 |a Kovrizhina  |b A. R.  |c biotechnology specialist  |c Research Engineer of Tomsk Polytechnic University  |f 1995-  |g Anastasia Ruslanovna  |9 22266 
701 1 |a Atochin  |b D. N.  |g Dmitry Nikolaevich 
701 1 |a Khlebnikov  |b A. I.  |c Chemist  |c Professor of Tomsk Polytechnic University  |f 1963-  |g Andrey Ivanovich  |9 17500 
712 0 2 |a National Research Tomsk Polytechnic University  |c (2009- )  |9 27197  |4 570 
801 0 |a RU  |b 63413507  |c 20241017 
850 |a 63413507 
856 4 |u https://doi.org/10.3390/molecules29163820  |z https://doi.org/10.3390/molecules29163820 
942 |c CR